EejungKimMD

Oncology • Boston, MA

Physician

Join to view full profile

Dr. Kim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kim's full profile

Already have an account?

Office
450 Brookline ave
Boston, MA 02215

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2016 - 2019
Harvard UniversityPh.D., Biological and Biomedical Sciences, 2012 - 2016
Yonsei University College of MedicineClass of 2010

Certifications & Licensure

MA State Medical License 2022 - 2026
VT State Medical License 2023 - 2025
CT State Medical License 2019 - 2023
OH State Medical License 2016 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Comprehensive structure-function analysis reveals gain- and loss-of-function mechanisms impacting oncogenic KRAS activity.
Jason J Kwon, Julien Dilly, Shengwu Liu, Eejung Kim, Yuemin Bian
Biorxiv. 2024-10-25
Deep-Transfer-Learning-Based Natural Language Processing of Serial Free-Text Computed Tomography Reports for Predicting Survival of Patients With Pancreatic Cancer.
Sunkyu Kim, Seung-Seob Kim, Eejung Kim, Michael Cecchini, Mi-Suk Park
JCO Clinical Cancer Informatics. 2024-08-01
Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer.
Rachael A Safyan, Eejung Kim, Emmelie Dekker, Marjolein Homs, Andrew J Aguirre
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2024-06-01

Press Mentions

Multidisciplinary Standards and Evolving Therapies for Patients with Pancreatic CancerMay 29th, 2024